GGrantIndex
← Leaderboards

Manus J Donahue

Vanderbilt University

Google Scholar ↗PubMed ↗ORCID ↗
$14,228,730
Attributed
$19,480,481
Total exposure
10
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3M · FY2012–25
$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$19,480,481 · 10

By mechanism

R01$19,090,587 · 9
R21$389,894 · 1

Top collaborators

Most similar at Vanderbilt University

Same institution · by research overlap

Others in their field

Top investigators on “Magnetic Resonance Imaging”

Research focus

Magnetic Resonance ImagingHemodynamicsTissuesImageReportingBrainMeasurementFunctional DisorderIn VivoBloodHigh RiskAdultImpairmentParticipantProceduresResponseEnrollmentBlood VesselsImaging ModalityStrokeReproducibilityAlzheimer&AposPhysiologyNeuroimaging

Grant awards (45)

Biomarkers of ischemic brain injury in adults with sickle cell disease$712,232
R01 · FY2025 · HL
Personalized hemodynamic and metabolic signatures of revascularization response in moyamoya disease$576,014
R01 · FY2025 · NS · contact PI
Quantitative imaging of choroid plexus function and neurofluid circulation in Alzheimer's Disease Related Dementia$568,763
R01 · FY2025 · AG · contact PI
Mechanisms of cerebral infarcts and brain oxygen utilization in anemia$431,490
R01 · FY2025 · NS · contact PI
Biomarkers of ischemic brain injury in adults with sickle cell disease$697,988
R01 · FY2024 · HL
Quantitative Imaging of Brain Glymphatic Function in Humans$606,558
R01 · FY2024 · AG · contact PI
Personalized hemodynamic and metabolic signatures of revascularization response in moyamoya disease$594,764
R01 · FY2024 · NS · contact PI
Quantitative imaging of choroid plexus function and neurofluid circulation in Alzheimer's Disease Related Dementia$580,371
R01 · FY2024 · AG · contact PI
Mechanisms of cerebral infarcts and brain oxygen utilization in anemia$418,546
R01 · FY2024 · NS · contact PI
Mechanisms of cerebral infarcts and brain oxygen utilization in anemia$134,374
R01 · FY2024 · NS · contact PI
Biomarkers of ischemic brain injury in adults with sickle cell disease$712,232
R01 · FY2023 · HL
Quantitative Imaging of Brain Glymphatic Function in Humans$606,558
R01 · FY2023 · AG · contact PI
Quantitative imaging of choroid plexus function and neurofluid circulation in Alzheimer's Disease Related Dementia$580,371
R01 · FY2023 · AG · contact PI
Mechanisms of cerebral infarcts and brain oxygen utilization in anemia$436,309
R01 · FY2023 · NS · contact PI
Quantitation of Glymphatic Functioning in Sleep and Meditative States$346,000
R01 · FY2023 · AT
Non-invasive, image-based, in-vivo assessment of tumor hypoxia to guide hypoxia-driven adaptive radiation therapy$158,251
R21 · FY2023 · CA
Mechanisms of cerebral infarcts and brain oxygen utilization in anemia$134,374
R01 · FY2023 · NS · contact PI
Biomarkers of ischemic brain injury in adults with sickle cell disease$712,232
R01 · FY2022 · HL
Quantitative Imaging of Brain Glymphatic Function in Humans$606,558
R01 · FY2022 · AG · contact PI
Mechanisms of cerebral infarcts and brain oxygen utilization in anemia$444,921
R01 · FY2022 · NS · contact PI
Imaging Biomarkers of Lymphatic Dysfunction$395,000
R01 · FY2022 · NR · contact PI
Quantitation of Glymphatic Functioning in Sleep and Meditative States$346,000
R01 · FY2022 · AT
Non-invasive, image-based, in-vivo assessment of tumor hypoxia to guide hypoxia-driven adaptive radiation therapy$231,643
R21 · FY2022 · CA
Quantitative Imaging of Brain Glymphatic Function in Humans$606,558
R01 · FY2021 · AG · contact PI
Imaging Biomarkers of Lymphatic Dysfunction$395,000
R01 · FY2021 · NR · contact PI
Quantitation of Glymphatic Functioning in Sleep and Meditative States$389,250
R01 · FY2021 · AT
Quantitative Imaging of Brain Glymphatic Function in Humans$600,651
R01 · FY2020 · AG · contact PI
Imaging Biomarkers of Lymphatic Dysfunction$395,000
R01 · FY2020 · NR · contact PI
Imaging collaterals and tissue metabolism in patients with Moyamoya syndrome$345,625
R01 · FY2020 · NS · contact PI
Quantification of Glymphatic Dysfunction in Patients with Alzheimer's Disease and Related Dementias$417,226
R01 · FY2019 · NR · contact PI
Imaging Biomarkers of Lymphatic Dysfunction$395,000
R01 · FY2019 · NR · contact PI
Imaging collaterals and tissue metabolism in patients with Moyamoya syndrome$345,625
R01 · FY2019 · NS · contact PI
Imaging Biomarkers of Lymphatic Dysfunction$395,000
R01 · FY2018 · NR · contact PI
Imaging collaterals and tissue metabolism in patients with Moyamoya syndrome$345,625
R01 · FY2018 · NS · contact PI
Imaging lymphatic function in patients with breast cancer related lymphedema$395,000
R01 · FY2017 · NR · contact PI
Imaging collaterals and tissue metabolism in patients with Moyamoya syndrome$345,625
R01 · FY2017 · NS · contact PI
Imaging lymphatic function in patients with breast cancer related lymphedema$395,000
R01 · FY2016 · NR · contact PI
Imaging collaterals and tissue metabolism in patients with Moyamoya syndrome$345,625
R01 · FY2016 · NS · contact PI
Characterizing Hemodynamic Compensation and Stroke Risk in Stenosis Patients$321,037
R01 · FY2016 · NS · contact PI
Imaging lymphatic function in patients with breast cancer related lymphedema$380,725
R01 · FY2015 · NR · contact PI
Characterizing Hemodynamic Compensation and Stroke Risk in Stenosis Patients$321,037
R01 · FY2015 · NS · contact PI
Imaging lymphatic function in patients with breast cancer related lymphedema$369,700
R01 · FY2014 · NR · contact PI
Characterizing Hemodynamic Compensation and Stroke Risk in Stenosis Patients$317,827
R01 · FY2014 · NS · contact PI
Characterizing Hemodynamic Compensation and Stroke Risk in Stenosis Patients$309,801
R01 · FY2013 · NS · contact PI
Characterizing Hemodynamic Compensation and Stroke Risk in Stenosis Patients$316,995
R01 · FY2012 · NS · contact PI